Ashfield Capital Partners’s Sanofi SNY Stock Holding History

Ashfield Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,318	Closed	-$223K	–	249
2016 Q2	$223K	Buy	5,318 +243	+5%	+$9.96K	0.02%	236
2016 Q1	$204K	Sell	5,075 -3,100	-38%	-$125K	0.01%	245
2015 Q4	$349K	Buy	8,175 +1,790	+28%	+$82.4K	0.02%	215
2015 Q3	$303K	Hold	6,385	–	–	0.02%	228
2015 Q2	$316K	Buy	6,385 +335	+6%	+$17K	0.02%	233
2015 Q1	$299K	Buy	+6,050	New	+$289K	0.02%	233
2014 Q3	–	Sell	-4,800	Closed	-$255K	–	281
2014 Q2	$255K	Buy	+4,800	New	+$255K	0.01%	251

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ashfield Capital Partners's SNY Position: Q3 2016 in Review

Ashfield Capital Partners sold out of Sanofi (SNY) in Q3 2016, closing a stake of 5,318 shares — an estimated $223K sold.

Ashfield Capital Partners first reported a position in SNY in Q2 2014 and held it in 7 quarters. The position peaked at $349K in Q4 2015. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

Ashfield Capital Partners reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
Ashfield Capital Partners sold 5,318 Sanofi shares in Q3 2016, an estimated $223K.
Ashfield Capital Partners first reported a position in Sanofi in Q2 2014 and held it in 7 quarters.
Ashfield Capital Partners's Sanofi position peaked at $349K in Q4 2015.
450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Ashfield Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.